Bioventus Inc Cl A (BVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 41,582 | 36,964 | 30,186 | 49,213 | 86,839 |
| Receivables | 127,393 | 122,789 | 136,295 | 124,963 | 88,283 |
| Inventories | 92,475 | 91,333 | 84,766 | 61,688 | 29,120 |
| Other current assets | 0 | 0 | 2,777 | 0 | 0 |
| TOTAL | $275,610 | $267,999 | $272,575 | $263,103 | $211,794 |
| Non-Current Assets | |||||
| PPE Net | 27,012 | 36,605 | 27,456 | 22,985 | 6,879 |
| Investments And Advances | 1,892 | 3,141 | 2,621 | 29,291 | 19,382 |
| Intangibles | 412,191 | 489,812 | 647,313 | 842,816 | 241,450 |
| Other Non-Current Assets | 11,251 | 13,353 | 422,684 | 67,667 | 14,961 |
| TOTAL | $452,346 | $542,911 | $1,100,074 | $962,759 | $282,672 |
| Total Assets | $727,956 | $810,910 | $1,372,649 | $1,225,862 | $494,466 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 27,339 | 27,848 | 33,056 | 18,038 | 15,000 |
| Accounts payable and accrued liabilities | 23,690 | 23,038 | 36,697 | 16,915 | 4,422 |
| Accrued Expenses | 135,879 | 119,795 | 111,570 | 142,348 | 99,241 |
| Other current liabilities | 23,490 | 4,816 | 122,694 | 3,558 | 3,926 |
| TOTAL | $210,398 | $175,497 | $304,017 | $180,859 | $122,589 |
| Non-Current Liabilities | |||||
| Long Term Debt | 308,288 | 366,998 | 385,010 | 339,644 | 173,378 |
| Other Non-Current Liabilities | 33,393 | 85,479 | 323,839 | 47,841 | 52,666 |
| TOTAL | $331,954 | $414,295 | $656,410 | $511,214 | $227,717 |
| Total Liabilities | $542,352 | $589,792 | $960,427 | $692,073 | $350,306 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 81,944 | 79,166 | 78,054 | 76,389 | N/A |
| Common Shares | 82 | 79 | 78 | 75 | N/A |
| Retained earnings | -355,078 | -321,536 | -165,306 | -6,602 | N/A |
| Other shareholders' equity | 35,091 | 48,321 | 86,874 | 75,044 | 144,160 |
| TOTAL | $185,604 | $221,118 | $412,222 | $533,789 | $144,160 |
| Total Liabilities And Equity | $727,956 | $810,910 | $1,372,649 | $1,225,862 | $494,466 |